F&P Healthcare's product pipeline expected to boost sales past $1b
Chief executive speaks on litigation costs, possible US tax hikes and product pipeline.
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Fisher & Paykel Healthcare’s [NZX:FPH] packed product pipeline will boost the medical device maker’s sales past the $1 billion mark, its management predicts.
The Auckland-based company reported a record profit today, up 18% to $169 million in the 12 months ended March 31.
Operating revenue
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Calida Smylie
Mon, 22 May 2017
Mon, 22 May 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
F&P Healthcare's product pipeline expected to boost sales past $1b
67150